Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
09/2005
09/21/2005EP1576175A2 Vascular-preferred promoters
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576151A2 Ap1 amine oxidase variants
09/21/2005EP1576145A2 Bioinformatically detectable group of novel viral regulatory genes and uses thereof
09/21/2005EP1576144A2 Proteorhodopsin mutants with improved optical characteristics
09/21/2005EP1576141A2 Polynucleotide encoding novel human g-protein coupled receptors, and splice variants thereof
09/21/2005EP1576124A2 Heat shock protein binding fragments of cd91, and uses thereof
09/21/2005EP1576118A2 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
09/21/2005EP1576116A2 Methods and materials relating to novel polypeptides and polynucleotides
09/21/2005EP1576108A2 Nitrilases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576103A2 Isolated polynucleotides and methods of promoting a morphology in a fungus
09/21/2005EP1576101A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
09/21/2005EP1576096A2 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
09/21/2005EP1576094A2 Methods of creating modified promoters resulting in varying levels of gene expression
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576059A2 Carboxamide-substituted dyes for analytical applications
09/21/2005EP1576042A2 Optical information carrier comprising immobilized proteorhodopsin
09/21/2005EP1576007A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders
09/21/2005EP1575990A2 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis
09/21/2005EP1575986A2 Peptides and methods for cell death regulation
09/21/2005EP1575985A2 INHIBITION OF Ii EXPRESSION IN MAMMALIAN CELLS
09/21/2005EP1575980A2 Rna interference
09/21/2005EP1575979A2 West nile virus vaccine
09/21/2005EP1575977A2 Immunostimulatory sequence oligonucleotides and methods of using the same
09/21/2005EP1575975A1 Process for the preparation of oligonucleotides
09/21/2005EP1575972A1 Nucleic acid labeling compounds
09/21/2005EP1575534A2 D4,5 glycuronidase and uses thereof
09/21/2005EP1575518A2 Compositions, organisms and methodologies employing a novel human kinase
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575498A2 Antisense modulation of microsomal prostaglandin e2 synthase expression
09/21/2005EP1575497A2 Novel composition and methods for the treatment of psoriasis
09/21/2005EP1575417A2 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005EP0752853B1 Human brain phosphodiesterase
09/21/2005CN1671865A Microparticle based signal amplification method and its application in the detection of analytes
09/21/2005CN1671729A Control sequences of the human Corin gene
09/21/2005CN1671398A Compositions and methods for treating epithelia and retinal tissue diseases
09/21/2005CN1670218A Method for screening salt-tolerant medicinal dandelion herb and its special primer
09/21/2005CN1219883C Engineering synthesized gene cry LC of pests-killing crystal protein of Bacillus thuringiensis Berliner
09/21/2005CN1219882C Method and combination for treating tumors based on ERBB-3
09/21/2005CN1219551C Conjugates made of metal complexes and oligonucleotides
09/20/2005US6947845 Method of identifying molecules that bind to the large ribosomal subunit
09/20/2005US6946575 for DNA analysis via fluorescent in situ hybridization (FISH)
09/20/2005US6946278 Serine proteases inhibitors comprising chymostrypsin site from transgenic plants; insect resistance
09/20/2005US6946275 Human testis specific serine/threonine kinase 1 and 2
09/20/2005US6946265 Genetic engineered polypeptides having replacements in the amino acid sequences, used as for prophylaxis of growth disorders such as turner's syndrome, muscular dystrophy, congestive heart failure, bone and metabolic disorders; stability
09/20/2005US6946262 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents
09/20/2005US6946261 gene expression cassettes comprising promoters joined to nucleic acids that code fusion proteins; peptide antibiotics; genetic engineering
09/20/2005US6946254 Amplification of HIV-1 gag sequences for detection of sequences associated with drug-resistance mutations
09/20/2005US6946252 Analzing preferential nucleotide sequences; obtain nucleotide sequences, incubate with primers bound to solid support, amplify, incubate with oligonucleotide probes, recover amplification poducts
09/20/2005US6946251 Methods and compositions for amplification of RNA sequences using RNA-DNA composite primers
09/20/2005US6946250 Separation of preferential nucleotide sequences; obtain sample, incubate with solid support, elute, recover preferential nucleotide sequences
09/20/2005US6946135 Prevention and treatment of amyloidogenic disease
09/20/2005US6946133 Prostate specific antigen oligo-epitope peptide
09/20/2005CA2226111C In situ preparation of nucleoside phosphoramidites and their use in synthesis of oligonucleotides
09/20/2005CA2189882C Papillomavirus vaccines
09/15/2005WO2005085850A1 Methods for multiplexed analyte detection
09/15/2005WO2005085477A1 Differential enzymatic fragmentation by whole genome amplification
09/15/2005WO2005085474A2 Fluorescent energy transfer labeled nucleic acid substrates and methods of use thereof
09/15/2005WO2005085468A1 Design and therapeutic use of adpase enhanced apyrases
09/15/2005WO2005085442A2 COMPOUNDS FOR HYDROLYSING RIBONUCLEIC ACIDS (RNAs)
09/15/2005WO2005085288A2 Natural igm antibodies and inhibitors thereof
09/15/2005WO2005085274A1 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients
09/15/2005WO2005085273A1 Thrombomodulin (thbd) haplotypes predict outcome of patients
09/15/2005WO2005085272A1 Boranophosphate monomer and process for producing oligonucleotide derivative therefrom
09/15/2005WO2005085270A1 Nucleic acid derivative having pyrrolyl group introduced in 5-position of pyridine ring
09/15/2005WO2005085269A1 Nucleotide derivatives and dna microarray
09/15/2005WO2005084714A2 Raav-neprilysin compositions and methods of use
09/15/2005WO2005084367A2 Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry
09/15/2005WO2005084272A2 Nucleic acid complexes
09/15/2005WO2005084210A2 Multiplex detection probes
09/15/2005WO2005084115A2 Ttg3 deficient plants, nucleic acids, polypetides and methods of use thereof
09/15/2005WO2005064020B1 Multiplexed nucleic acid analysis with high specificity
09/15/2005WO2005056569A3 Beta integrin gene and protein
09/15/2005WO2005052148A3 Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates
09/15/2005WO2005052127A3 Real-time detection of nucleic acids and proteins
09/15/2005WO2005044982A3 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells
09/15/2005WO2005040428A3 Detection of mutations in a gene associated with resistance to viral infection, oas1
09/15/2005WO2005038001A3 Improved transgenesis by sperm-mediated gene transfer
09/15/2005WO2005031350A3 Human protein acyl transferases and methods of uses therefor
09/15/2005WO2005012579A3 Homodimeric cyanine dye dimer comprising aromatic, heteroaromatic, cyclic or heterocyclic linker moiety in nucleic acid reporter molecules
09/15/2005WO2005012499A3 Methods for amplifying polymeric nucleic acids
09/15/2005WO2005007871A3 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof
09/15/2005WO2005007663A9 Fluorogenic enzyme substrates and uses thereof
09/15/2005WO2004111200A3 Rtvp-glipr-like compositions and methods for the detection, treatment and prevention of prostate cancer
09/15/2005WO2004096997A3 Molecular detection systems utilizing reiterative oligonucleotide synthesis
09/15/2005WO2004094606A3 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2
09/15/2005WO2004093810A3 Methods and compositions for treating disorders
09/15/2005WO2004089284A3 Targets for tumor growth inhibition
09/15/2005WO2004047764A3 Modulation of hiv replication by rna interference
09/15/2005WO2003000844A3 Protein modification and maintenance molecules
09/15/2005WO2002085519A3 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon
09/15/2005US20050204429 polynucleotide constructs, expression cassettes, vectors, or inserts into the chromosome or as an exogenous element, to modulate in vivo and in vitro transcription of polynucleotides; host cells, plants and seeds
09/15/2005US20050204419 Expression vector coding resistance polypeptide (RB) for use in transformation and geneation of disease resistant tomatoes and potatoes
09/15/2005US20050204417 Expression vector comprising nucleotide sequences coding novel transferase for generation of plants with increased metabolic flux toward monoterpenes; improving production of essential oils in plants
09/15/2005US20050204412 Artery- and vein-specific proteins and uses therefor
09/15/2005US20050204408 Imparting and/or enhancing glycosaminoglycan binding of water soluble protein via linkage of gene sequences to growth factors, cytokines and/or antibodies
09/15/2005US20050204406 Expression vector comprising nucleotide sequences coding blood coagulation factor for use as heterologous gene expression tool; treating blood disorders; bioreactor for producing secreted proteins
09/15/2005US20050203289 Functional biopolymer modification reagents and uses thereof
09/15/2005US20050203280 Nucleotide sequences coding gramnegative microorganismal genomic sequences for use as tool in diagnosing middle ear infection
1 ... 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 ... 899